N Engl J Med 376(24):23492357 Cherney DZI, Perkins BA, Soleymanlou N, Maione M, Lai V, Lee A et al (2014) Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus
Angiotensin-Converting Enzyme 2 and Angiotensin 1-7: Novel Therapeutic Targets
Reported Issues: Consumers report: That this product did not lead to weight loss or appetite suppression as advertised That this product was marketed using misleading claims about GLP-1 support That they paid for a product that did not provide the promised benefits That the supplements were promoted as alternatives to GLP-1 medications, despite not functioning like prescription GLP-1 drugs That marketing materials imply that these supplements are scientifically and medically proven and reliable, when evidence may be lacking That they would not have purchased the supplements if they had known the claims were not supported by reliable scientific evidence Why Individuals Should Be Concerned: Potential claims include: Economic loss False advertising Product defect Performance vs
It contains 0g sugar and 9g protein per serving
Normal growth and development in the absence of hepatic insulin-like growth factor I. Proceedings of the National Academy of Sciences
In this regard, it has been demonstrated that parenteral substitution of Se reduced mortality and infection rate in sepsis syndromes [18]